Evidence map›Paper›PMID 27048806›Full record

ArticlemBio2016

Gliotoxin Suppresses Macrophage Immune Function by Subverting Phosphatidylinositol 3,4,5-Trisphosphate Homeostasis.

Daniel Schlam, Johnathan Canton, Marvin Carreño, Hannah Kopinski, Spencer A Freeman, Sergio Grinstein, Gregory D Fairn

Abstract read
In one paragraph

Article in mBio, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed.

  1. Repurposing FDA-Approved Drugs to Inhibit Fungal PPTases for Broad-Spectrum Synergy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. Molecular mechanisms drivingFrontiers in molecular biosciences · 2026
    Review
  4. Immune interaction betweenFrontiers in cellular and infection microbiology · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. Membrane Ruffles: Composition, Function, Formation and Visualization.International journal of molecular sciences · 2024
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. COVID-19-associated fungal infections.Nature microbiology · 2022
    Review
  18. Review
  19. Exposure to theMicrobiology (Reading, England) · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Daniel SchlamDivision of Cell Biology, Hospital for Sick Children, Toronto, Ontario, Canada Faculty of Medicine, Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
Johnathan CantonDivision of Cell Biology, Hospital for Sick Children, Toronto, Ontario, Canada.
Marvin CarreñoDivision of Cell Biology, Hospital for Sick Children, Toronto, Ontario, Canada.
Hannah KopinskiDivision of Cell Biology, Hospital for Sick Children, Toronto, Ontario, Canada.
Spencer A FreemanDivision of Cell Biology, Hospital for Sick Children, Toronto, Ontario, Canada.
Sergio GrinsteinDivision of Cell Biology, Hospital for Sick Children, Toronto, Ontario, Canada Faculty of Medicine, Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, Ontario, Canada.
Gregory D FairnFaculty of Medicine, Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, Ontario, Canada Departments of Surgery and Biochemistry, University of Toronto, Toronto, Ontario, Canada fairng@smh.ca.

Funding

Canadian Institutes of Health Research FDN-143202Canadian Institutes of Health Research MOP-133656
6 · The paper itself

Abstract

unlabelledAspergillus fumigatus, an opportunistic fungal pathogen, spreads in the environment by releasing numerous conidia that are capable of reaching the small alveolar airways of mammalian hosts. In otherwise healthy individuals, macrophages are responsible for rapidly phagocytosing and eliminating these conidia, effectively curbing their germination and consequent invasion of pulmonary tissue. However, under some circumstances, the fungus evades phagocyte-mediated immunity and persists in the respiratory tree. Here, we report thatA. fumigatusescapes macrophage recognition by strategically targeting phosphatidylinositol 3,4,5-trisphosphate [PtdIns(3,4,5)P3] metabolism through gliotoxin, a potent immunosuppressive mycotoxin. Time-lapse microscopy revealed that, in response to the toxin, macrophages cease to ruffle, undergo abrupt membrane retraction, and fail to phagocytose large targets effectively. Gliotoxin was found to prevent integrin activation and interfere with actin dynamics, both of which are instrumental for phagocytosis; similar effects were noted in immortalized and primary phagocytes. Detailed studies of the underlying molecular mechanisms of toxicity revealed that inhibition of phagocytosis is attributable to impaired accumulation of PtdIns(3,4,5)P3and the associated dysregulation of downstream effectors, including Rac and/or Cdc42. Strikingly, in response to the diacylglycerol mimetic phorbol 12-myristate 13-acetate, gliotoxin-treated macrophages reactivate beta integrins, reestablish actin dynamics, and regain phagocytic capacity, despite the overt absence of plasmalemmal PtdIns(3,4,5)P3 Together, our findings identify phosphoinositide metabolism as a critical upstream target of gliotoxin and also indicate that increased diacylglycerol levels can bypass the requirement for PtdIns(3,4,5)P3signaling during membrane ruffling and phagocytosis. IMPORTANCE: Aspergillus fumigatusis the most frequent cause of human infections in theAspergillusgenus. In immunocompromised populations, invasive aspergillosis (IA) is associated with a mortality rate of up to 90%, and current antifungal therapies have failed to prevent or reverse the infection. Therefore, a deeper understanding of the interactions betweenA. fumigatusand its host is required. In healthy humans, alveolar macrophages can ingest and eliminate fungal spores, thus limiting their germination into mycotoxin-producing hyphae. Our studies reveal that gliotoxin-the most abundantAspergillusmycotoxin-undermines the ability of phagocytes to carry out their protective functions. By targeting PtdIns(3,4,5)P3signaling and downregulating phagocytic immune defenses, the toxin could also exacerbate polymicrobial infections. Notably, we were able to reverse gliotoxin toxicity by addition of diacylglycerol analogues, which may provide the basis for therapeutic interventions.

Indexed as

AnimalsAspergillus fumigatusCells, CulturedGliotoxinHomeostasisHumansImmune EvasionMacrophagesMiceMicroscopyPhagocytosisPhosphatidylinositol PhosphatesTime-Lapse ImagingGliotoxinphosphatidylinositol 3,4,5-triphosphatePhosphatidylinositol Phosphates

Identifiers

PMID27048806
PMCPMC4817266

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.